Human interactome of the influenza B virus NS1 protein

Journal of General Virology

Volumn 98, Issue 9, 2017, Pages 2267-2273

  Patzina, Corinna ^a   Botting, Catherine H ^b   García Sastre, Adolfo ^c   Randall, Richard E ^b   Hale, Benjamin G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza; Interferon; Proteomics; Virulence factor; Virus host interaction

Indexed keywords

ANXA2 PROTEIN; DHX9 PROTEIN; HNRNPA2B1 PROTEIN; HNRNPC PROTEIN; HNRNPH3 PROTEIN; HNRNPU PROTEIN; HOST FACTOR; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN ENHANCER BINDING FACTOR 3; MATR3 PROTEIN; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; NUCLEOPHOSMIN; PABPC1 PROTEIN; PNN PROTEIN; PRPF8 PROTEIN; RALY PROTEIN; RBMY1A1 PROTEIN; REGULATOR PROTEIN; RNA BINDING PROTEIN; RNPS1 PROTEIN; RPL3 PROTEIN; RPL6 PROTEIN; SNRNP200 PROTEIN; SRRM2 PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1; ZNF326 PROTEIN; DEAD BOX PROTEIN; DHX9 PROTEIN, HUMAN; ILF3 PROTEIN, HUMAN; INS1 PROTEIN, INFLUENZA VIRUS; PROTEIN BINDING; TUMOR PROTEIN; VIRAL PROTEIN; YBX1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFLUENZA B VIRUS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA-BINDING DOMAIN; STABLE EXPRESSION; VIRUS REPLICATION; GENETICS; INFLUENZA; ISOLATION AND PURIFICATION; METABOLISM; VIROLOGY;

DEAD-BOX RNA HELICASES; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NEOPLASM PROTEINS; NUCLEAR FACTOR 90 PROTEINS; PROTEIN BINDING; VIRAL NONSTRUCTURAL PROTEINS; Y-BOX-BINDING PROTEIN 1;

EID: 85029595752     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000909     Document Type: Article

References (46)

1. Koutsakos M, Nguyen TH, Barclay WS, Kedzierska K. Knowns and unknowns of influenza B viruses. Future Microbiol 2016;11:119-135.
2. Palese P, Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Knipe DM and Howley PM (editors). Fields Virology. Lippincott Williams & Wilkins; 2013. pp. 1151-1185.
3. Dauber B, Heins G, Wolff T. The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 2004;78:1865-1872.
4. Dauber B, Schneider J, Wolff T. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol 2006;80:11667-11677.
5. Zhao C, Sridharan H, Chen R, Baker DP, Wang S et al. Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins. Nat Commun 2016;7:12754.
6. Krug RM. Functions of the influenza A virus NS1 protein in antiviral defense. Curr Opin Virol 2015;12:1-6.
7. Jackson D, Elderfield RA, Barclay WS. Molecular studies of influenza B virus in the reverse genetics era. J Gen Virol 2011;92:1-17.
8. Donelan NR, Dauber B, Wang X, Basler CF, Wolff T et al. The Nand C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol 2004;78:11574-11582.
9. Hale BG. Conformational plasticity of the influenza A virus NS1 protein. J Gen Virol 2014;95:2099-2105.
10. Wang W, Krug RM. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 1996;223:41-50.
11. Yin C, Khan JA, Swapna GV, Ertekin A, Krug RM et al. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 2007;282:20584-20592.
12. Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 2003;307:386-395.
13. Ehrhardt C, Wolff T, Ludwig S. Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. J Virol 2007;81:12097-12100.
14. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85b and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 2006;103:14194-14199.
15. Yuan W, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J 2001;20:362-371.
16. Guan R, Ma LC, Leonard PG, Amer BR, Sridharan H et al. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus. Proc Natl Acad Sci USA 2011;108:13468-13473.
17. Versteeg GA, Hale BG, van Boheemen S, Wolff T, Lenschow DJ et al. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol 2010;84:5423-5430.
18. Kochs G, García-Sastre A, Martínez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007;81:7011-7021.
19. Ayllon J, Domingues P, Rajsbaum R, Miorin L, Schmolke M et al. A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol 2014;88:12146-12151.
20. Melén K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein:striking differences between different virus subtypes. J Virol 2007;81:5995-6006.
21. Schneider J, Dauber B, Melén K, Julkunen I, Wolff T. Analysis of influenza B Virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains. J Virol 2009;83:701-711.
22. Hilton L, Moganeradj K, Zhang G, Chen YH, Randall RE et al. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 2006;80:11723-11732.
23. Didcock L, Young DF, Goodbourn S, Randall RE. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 1999;73:9928-9933.
24. Chang YG, Yan XZ, Xie YY, Gao XC, Song AX et al. Different roles for two ubiquitin-like domains of ISG15 in protein modification. J Biol Chem 2008;283:13370-13377.
25. Dauber B, Martínez-Sobrido L, Schneider J, Hai R, Waibler Z et al. Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog 2009;5:e1000473.
26. Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R et al. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 2012;487:486-490.
27. Sadewasser A, Saenger S, Paki K, Schwecke T, Wolff T. Disruption of Src homology 3-binding motif within non-structural protein 1 of influenza B virus unexpectedly enhances viral replication in human cells. J Gen Virol 2016;97:2856-2867.
28. Patel RC, Vestal DJ, Xu Z, Bandyopadhyay S, Guo W et al. DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J Biol Chem 1999;274:20432-20437.
29. Landthaler M, Gaidatzis D, Rothballer A, Chen PY, Soll SJ et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 2008;14:2580-2596.
30. Shabman RS, Gulcicek EE, Stone KL, Basler CF. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin a1 and partially alters its nuclear import. J Infect Dis 2011;204:S904-S910.
31. Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA 2014;5:95-110.
32. Kawaguchi A, Matsumoto K, Nagata K. YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. J Virol 2012;86:11086-11095.
33. Kawaguchi A, Hirohama M, Harada Y, Osari S, Nagata K. Influenza virus induces cholesterol-enriched endocytic recycling compartments for budozone formation via cell cycle-independent centrosome maturation. PLoS Pathog 2015;11:e1005284.
34. Ma LC, Guan R, Hamilton K, Aramini JM, Mao L et al. A second RNA-binding site in the NS1 protein of nfluenza B virus. Structure 2016;24:1562-1572.
35. Jiang J, Li J, Fan W, Zheng W, Yu M et al. Robust Lys63-linked ubiquitination of RIG-I promotes cytokine eruption in early influenza B virus infection. J Virol 2016;90:6263-6275.
36. Chen S, Short JA, Young DF, Killip MJ, Schneider M et al. Heterocellular induction of interferon by negative-sense RNA viruses. Virology 2010;407:247-255.
37. Tremblay N, Baril M, Chatel-Chaix L, Es-Saad S, Park AY et al. Spliceosome SNRNP200 promotes viral RNA sensing and IRF3 activation of antiviral response. PLoS Pathog 2016;12:e1005772.
38. Bortz E, Westera L, Maamary J, Steel J, Albrecht RA et al. Hostand strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio 2011;2:e00151-11.
39. Wang P, Song W, Mok BW, Zhao P, Qin K et al. Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. J Virol 2009;83:7850-7861.
40. Wen X, Huang X, Mok BW, Chen Y, Zheng M et al. NF90 exerts antiviral activity through regulation of PKR phosphorylation and stress granules in infected cells. J Immunol 2014;192:3753-3764.
41. Isken O, Baroth M, Grassmann CW, Weinlich S, Ostareck DH et al. Nuclear factors are involved in hepatitis C virus RNA replication. RNA 2007;13:1675-1692.
42. Isken O, Grassmann CW, Sarisky RT, Kann M, Zhang S et al. Members of the NF90/NFAR protein group are involved in the life cycle of a positive-strand RNA virus. Embo J 2003;22:5655-5665.
43. Gomila RC, Martin GW, Gehrke L. NF90 binds the dengue virus RNA 3' terminus and is a positive regulator of dengue virus replication. PLoS One 2011;6:e16687.
44. Li Y, Masaki T, Shimakami T, Lemon SM. hnRNP L and NF90 interact with hepatitis C virus 5'-terminal untranslated RNA and promote efficient replication. J Virol 2014;88:7199-7209.
45. Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE et al. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J Infect Dis 2011;204:S911-S918.
46. Patiño C, Haenni AL, Urcuqui-Inchima S. NF90 isoforms, a new family of cellular proteins involved in viral replication? Biochimie 2015;108:20-24.